πŸ‡ΊπŸ‡Έ FDA
Patent

US 9486446

Orally disintegrating solid preparation

granted A61KA61K31/4439A61K31/444

Quick answer

US patent 9486446 (Orally disintegrating solid preparation) held by Takeda Pharmaceutical Company Limited expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4439, A61K31/444, A61K9/0056, A61K9/2081